[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

January 2024 | 43 pages | ID: RB385C20295EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Rigel Pharmaceuticals, Inc. %li%Company Profile and SWOT Analysis

Summary

Rigel Pharmaceuticals, Inc. %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a biotechnology company that discovers, develops and provides novel small molecule drugs. Its products are used in immunology, inflammatory, autoimmune, oncology, hematology and immuno-oncology related therapeutic areas. Its products include IgAN, autoimmune hemolytic anemia, and immune thrombocytopenic. The company conducts various clinical trials and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. Rigel Pharmaceuticals collaborates with various pharmaceutical companies for developing therapeutic drugs. It markets its products through partnerships in various geographical regions including the North America, Europe, and Asia-Pacific. The company is headquartered in South San Francisco, California, the US.

Scope
  • Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
  • Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Rigel Pharmaceuticals, Inc.: Company Overview
Rigel Pharmaceuticals, Inc.: Overview and Key Facts
Rigel Pharmaceuticals, Inc.: Overview
Rigel Pharmaceuticals, Inc.: Key Facts
Rigel Pharmaceuticals, Inc.: Key Employees
Rigel Pharmaceuticals, Inc.: Key Employee Biographies
Rigel Pharmaceuticals, Inc.: Major Products and Services
Rigel Pharmaceuticals, Inc.: Management Statement
Rigel Pharmaceuticals, Inc.: Key Competitors
Rigel Pharmaceuticals, Inc.: Company Analysis
Rigel Pharmaceuticals, Inc.: Business Description
Rigel Pharmaceuticals, Inc.: SWOT Analysis
Rigel Pharmaceuticals, Inc.: SWOT Overview
Rigel Pharmaceuticals, Inc.: Strengths
Rigel Pharmaceuticals, Inc.: Weaknesses
Rigel Pharmaceuticals, Inc.: Opportunities
Rigel Pharmaceuticals, Inc.: Threats
Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Rigel Pharmaceuticals, Inc.: Financial Deals Overview
Rigel Pharmaceuticals, Inc.: Targets and Partners
Rigel Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
Rigel Pharmaceuticals, Inc.: Partnership
Rigel Pharmaceuticals, Inc.: Recent Developments
Rigel Pharmaceuticals, Inc.: News and Events Summary
Rigel Pharmaceuticals, Inc.: Financial Deals
Rigel Pharmaceuticals, Inc.: Financial Performance
Rigel Pharmaceuticals, Inc.: Market Developments
Rigel Pharmaceuticals, Inc.: Research & Development
Rigel Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

LIST OF TABLES

Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
Table 3: Rigel Pharmaceuticals, Inc.: Key Competitors
Table 4: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 6: Rigel Pharmaceuticals, Inc.: Targets and Partners
Table 7: Rigel Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
Table 8: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 9: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 10: Rigel Pharmaceuticals, Inc.: News and Events Summary
Table 11: Rigel Pharmaceuticals, Inc.: Financial Deals
Table 12: Rigel Pharmaceuticals, Inc.: Financial Performance
Table 13: Rigel Pharmaceuticals, Inc.: Market Developments
Table 14: Rigel Pharmaceuticals, Inc.: Research & Development
Table 15: Rigel Pharmaceuticals, Inc.: Strategy and Operations

LIST OF FIGURES

Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 4: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)


More Publications